Raymond James & Associates Homology Medicines, Inc. Transaction History

Raymond James & Associates

  • $146 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024
SELL
$0.53 - $1.14 $1,590 - $3,419
-3,000 Reduced 18.85%
12,919 $7,000
Q4 2022

Feb 08, 2023
SELL
$1.09 - $2.04 $1,035 - $1,938
-950 Reduced 5.63%
15,919 $20,000
Q1 2022

May 11, 2022
BUY
$2.6 - $4.17 $43,859 - $70,343
16,869 New
16,869 $51,000

Others Institutions Holding FIXX

# of Institutions
5
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email